Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$43.67
+5.31%
Mkt Cap $3.04B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (19 analysts)
$75.14
Range $65.00 – $82.00
Implied Upside
+72.1%
Consensus $75.14 vs current $43.67
NASDAQ·Healthcare·Biotechnology
$43.67
+5.31%
Mkt Cap $3.04B
Buy
11
Hold
0
Sell
0
Price Target (19 analysts)
$75.14
Range $65.00 – $82.00
+72.1%
Consensus $75.14 vs current $43.67